Ronald W. Busuttil

University of California, Los Angeles — United States

Medicine · Health Sciences

116h-index51.0kcitations1.0kworks0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Organ Transplantation Techniques and Outcomes(467), Liver Disease and Transplantation(366), Liver Disease Diagnosis and Treatment(179), Renal Transplantation Outcomes and Treatments(104), Hepatocellular Carcinoma Treatment and Prognosis(84)

Publications996 total

Diagnosis and Management of Post–Liver Transplant Biliary Obstruction: 1,300 Patient Single-Center Experience
Journal of the American College of Surgeons·2025
Occult multifocal and incidental hepatocellular carcinoma: An analysis of long-term survival and risk factors at a single liver transplant center
Liver Transplantation·2025
Two-Stage Approach to Intestinal and Multi Visceral Transplantation: Analysis of Pre-transplant Predictors and Post-transplant Outcomes
Intestinal failure.·2025Open Access
Intestinal Re-Transplantation
Gastroenterology Clinics of North America·2024· 1 cited
Myeloid spatial and transcriptional molecular signature of ischemia-reperfusion injury in human liver transplantation
Hepatology Communications·2024· 2 citedOpen Access
Outcomes after intestinal re-transplant: A detailed, single-center analysis of clinical and technical factors
Intestinal failure.·2024· 2 citedOpen Access
Immune Features of Disparate Liver Transplant Outcomes in Female Hispanics With Nonalcoholic Steatohepatitis
Transplantation Direct·2023· 1 citedOpen Access
P617 Alloimmune endotypes and related outcomes in human liver transplantation
Human Immunology·2023
Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation
American Journal of Transplantation·2023· 22 citedOpen Access
The Evolution of Redo Liver Transplantation Over 35 Years
Annals of Surgery·2023· 8 cited
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium
Liver Transplantation·2023· 41 citedOpen Access
Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium
Liver Transplantation·2022· 15 cited
Gsk3β regulates the resolution of liver ischemia/reperfusion injury via MerTK
JCI Insight·2022· 23 citedOpen Access
HCC EV ECG score: An extracellular vesicle‐based protein assay for detection of early‐stage hepatocellular carcinoma
Hepatology·2022· 83 citedOpen Access
Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma
JAMA Surgery·2022· 136 citedOpen Access
Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation
Liver Transplantation·2022· 17 citedOpen Access
Operational tolerance is not always permanent
Liver Transplantation·2022· 6 cited
New ERAS in liver transplantation – Past, present, and next steps
Clinical Transplantation·2022· 8 cited
Fractional Flow Reserve in End-Stage Liver Disease
The American Journal of Cardiology·2021· 4 citedOpen Access
Perioperative Skeletal Muscle Fluctuations in High-Acuity Liver Transplantation
Journal of Surgical Research·2021· 10 cited
page 1 of 50Next →

Frequent Co-authors

Douglas G. Farmer(13), Jerzy W. Kupiec‐Weglinski(11), Hasan Yersiz(10), Jonathan R. Hiatt(10), Charles Lassman(9), Johnny C. Hong(6), Vatche G. Agopian(6), Curtis Holt(6), David Lu(6), Myron J. Tong(6), Sue V. McDiarmid(6), Sammy Saab(6), Rafik M. Ghobrial(5), Leonard I. Goldstein(5), Steven S. Raman(5), Paul Martin(4), Farin Amersi(4), Richard S. Finn(4), Ali Zarrinpar(4), Yuan Zhai(3)